Navigation Links
ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
Date:1/8/2009

d on developing and commercializing genetically targeted therapies for heart failure and other cardiovascular diseases. The Company's lead product candidate, Gencaro(TM) (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. ARCA has identified common genetic variations that it believes predict individual patient response to Gencaro. The New Drug Application for approval of Gencaro for the indication of chronic heart failure, including the proposed brand name, is currently under review by the U.S. Food and Drug Administration. The companion genetic test for Gencaro is in development by ARCA's partner, Laboratory Corporation of America. For more information please visit http://www.arcabiopharma.com.

About Nuvelo

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. Nuvelo's development pipeline includes NU172, a direct thrombin inhibitor which has completed Phase 1 development for use as a potential short-acting anticoagulant during medical or surgical procedures; and NU206, a Wnt pathway modulator in Phase 1 development for the potential treatment of chemotherapy/radiation therapy-induced mucositis and inflammatory bowel disease. In addition, Nuvelo is pursuing research programs in leukemia and lymphoma therapeutic antibodies and Wnt signaling pathway therapeutics to further expand its pipeline and create additional partnering and licensing opportunities.

Information about Nuvelo is available at its website at http://www.nuvelo.com or by phoning 650-517-8000.

Forward-looking statements

This press release conta
'/>"/>

SOURCE ARCA biopharma, Inc. and Nuvelo, Inc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
2. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
3. Helix BioPharma Announces Q1 2009 Financial Results
4. McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries
5. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
6. XTL Biopharmaceuticals Implements Restructuring Plan
7. Nuvelo and ARCA biopharma Advance Toward Completion of Merger
8. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
9. MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
10. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
11. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ease is a research industry first, allowing veteri...search safety study data to be managed in one soft... Knolls, NJ (PRWEB) November 9, 2009 -- Xybion Med...Pristima™ VM, an integrated enterprise softw...e use and care of veterinary research subjects. Pr...
(Date:11/9/2009)...ire/ -- Following the provision of clinical,and sc...on (FDA), privately,owned UK company Daval Interna... ) has been informed that its innovative,anti-infl...an-Drug,designation for the treatment of Amyotroph...nown as Lou Gehrig,s disease, is the most common f...
(Date:11/8/2009)...tures and energy costs continue to soar, renewable...ture. An attractive replacement for gasoline is ...enome Research ( www.genome.org ), scientists hav...ducing microorganisms, uncovering genetic clues th... needed to implement production on a global scale....
(Date:11/8/2009)...5, 2009 Complete Genomics, a third-generation hum...ication of a report in the journal Science descr...luding analysis of sequence data from three comple...hree genomes sequenced on the proof-of-principle g...overage to $1,726 for 45x coverage for the samples...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...NEW YORK, Feb. 19 Cowen Group, Inc. (Nasdaq:,COWN...nnounced today that,Matthew Q. Reber has been hire...Reber is based in Connecticut and rejoins founders...ch, the Managing Directors of CHRP,with whom he pr...to joining CHRP, Mr. Reber worked at Accretive LLC...
...ANN ARBOR, Mich., Feb. 19 MichBio, the associatio...apa, chairman and chief,executive officer of Alleg...er for its April 22 Annual Meeting in Ann Arbor. P...eed for Quality, Affordable Healthcare,Products.",... and chief executive,officer. He was elected to th...
...MOUNTAINSIDE, N.J., Feb. 19 National Stem,Cell Ho...ment of Burt,Martin Arnold Securities, Inc. ("BMA ...nking services with respect to assisting and advis...,500,000., BMA Securities is a FINRA member full ...de array of financial services, which include: mar...
Other Biology Technology:Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 2MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop 2National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000 2
(Date:11/9/2009)...BER 9, 2009 A nutritionist whose research was ins...ederal Women, Infants and Children (WIC) food subs...Award for outstanding achievement in the field of ...D., MNS, , a professor in the Department of Commun...a, Los Angeles School of Public Health, will recei...
(Date:11/8/2009)...nd. - Researchers at Purdue University have discov...bers in spinal cord injuries using nano-spheres th...an accident. , The synthetic "copolymer micelles... diameter, or roughly 100 times smaller than the d...been studying how to deliver drugs for cancer trea...
(Date:11/8/2009)..., 2009) The loss of a gene through deletion of ge... significant abnormalities in learning and behavio...College of Medicine ( www.bcm.edu ) in a report th...etics . , "This research goes about 95 percent o...group of individuals to this gene," said Dr. Arthu...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Developmental delay could stem from nicotinic receptor deletion 2Regulatory Affairs Professionals Society 28RAPS 29 Honors 2009 RAPS Fellows 57051 1Regulatory Affairs Professionals Society 28RAPS 29 Honors 2009 RAPS Fellows 57051 2Regulatory Affairs Professionals Society 28RAPS 29 Honors 2009 RAPS Fellows 57051 3RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 1RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 2RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 3Dermatologists Screen More Than 1 300 People for Skin Cancer at Kentucky State Fair 57047 1Dermatologists Screen More Than 1 300 People for Skin Cancer at Kentucky State Fair 57047 2Dermatologists Screen More Than 1 300 People for Skin Cancer at Kentucky State Fair 57047 3
...m Inc., announced today that it has been awarded a...nited States Defense Threat Reduction Agency (DTRA...inners of this award were selected after an intens... academic, government, and industrial labs. , Nan...gnostics, have been privately developing Gene-RADA...
... million gift to the University of Michigan Health... institute one with a mission of supporting funda...e causes, treatment and prevention of a broad rang...cal Research Institute, being established in the U... whose funding and vision led to its creation. Mr....
...amounts of caffeine while taking acetaminophen, on...d States, could potentially cause liver damage, ac... in the Oct. 15 print issue of ACS Chemical Resear...eraction could occur not only from drinking caffei...so from using large amounts of medications that in...
Other Biology News:Nanobiosym awarded $2 million DTRA contract 2$22 million gift from Alfred Taubman launches new biomedical research institute 2$22 million gift from Alfred Taubman launches new biomedical research institute 3$22 million gift from Alfred Taubman launches new biomedical research institute 4Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 2
...ro-fractionation, spotting and preparation for MS ...be accurately and continuously spotted onto target...ic preparation of target plates for MALDI-TOF-MS m...us Two-Dimensional Micro LC System and Shimadzu Bi...
...inase) signal transduction cascade is one of three...thway activation occurs in response to environment...tion of JNK itself, and is implicated in the immun...sformation, morphogenesis, and apoptosis.JIP1 (JNK...
HP GenomeWide siRNA from QIAGEN
... Panels were designed for full-length gene cloning...he desired cDNA clone. The first PCR analysis is p...ell contains plasmid DNA from 5,000 clones. Having...resis of the reaction products, the second PCR ana...
Biology Products: